Fair Value Calculator Fair Value Calculator
EN DE

Trident Texofab Limited (TTFL) Fair Value & Analysis

Consumer Cyclical · IN · Market cap ₹513M

TT Trident Texofab Limited TTFL · BSE
Price₹34.19
Fair Value₹9.40
Upside-72.5%
Quality24/100
Watch Trident Texofab Limited for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹7.05 – ₹11.75

Fair value as of: Jul 6, 2026

From 17 valuation models · updated today

Share price −14.7% over the past month.

Price vs Fair Value (12 months)

₹379.00 ₹34.19 Fair Value ₹9.40 Jul 2025 Jul 2026

12‑month range ₹34.19 – ₹379.00 · fair‑value band ₹7.05 – ₹11.75 · the ₹34.19 price screens above the ₹9.40 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Trident Texofab Limited (TTFL) currently trades at ₹34.19, while our model-based Fair Value estimate is ₹9.40 — implying the stock looks roughly 72.5% overvalued today. We read business quality at 24/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, Trident Texofab Limited generated revenue of ₹1.2B at a net margin of 0.6%. Revenue declined 12.1% year over year. It earns a return on equity of 1.4%. Net debt stands at ₹335M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹7.05 (bear case) to ₹11.75 (bull case); at ₹34.19, the current price sits above that range. For context, the median of 10 Consumer Cyclical peers we cover trades at -37% fair-value upside — at -73%, TTFL screens richer than that median.

Key figures & financial health

Revenue (TTM) ₹1.2B
Revenue growth (YoY) -12.1%
Net margin 0.6%
Return on equity 1.4%
Free cash flow −₹102M FY2026
P/E ratio 63.3
More key figures
Operating margin -4.4%
EPS (TTM) ₹0.5400
EPS growth (YoY) +94.7%
Net debt ₹335M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

About the company

Trident Texofab Limited engages in the manufacture and wholesale trading of textile fabric cloth in India. The company offers grey, embroidered, digital printed, polyester, and poly-blend fabrics; bed sheets; technical textiles; suiting products; and value-added products in embroidery. It also offers contract manufacturing digital printing services. In addition, the company trades in home furnishing products comprising bed sheets, curtains, cushion covers, pillows, and upholstery; and clothing articles, including scarves, pareos, suiting, shirting, and technical textile fabrics. It distributes its products under the Storia of Shed, Light Trail, Comfy Zoi, and Alicon brands. Trident Texofab Limited was incorporated in 2008 and is based in Surat, India.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Trident Texofab Limited reported revenue of ₹1.2B in FY2026 versus ₹843M in FY2022, a compound +8.8%/yr. Reported net income was ₹7.0M in FY2026, compounding −8.0%/yr from FY2022.

Revenue +8.8%/yr
FY22 ₹843M
FY23 ₹964M
FY24 ₹995M
FY25 ₹1.2B
FY26 ₹1.2B
Net income −8.0%/yr
FY22 ₹9.8M
FY23 ₹22.2M
FY24 ₹10.8M
FY25 ₹25.1M
FY26 ₹7.0M

Is TTFL fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Trident Texofab Limited Fair Value". https://www.fairvalue-calculator.com/stock/TTFL

Similar stocks

10 more Textile Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 6, 2026).

Stock Price Fair Value vs Fair Value
Toray Industries, Inc TRYIF $7.90 $6.29 -20%
Shenzhou International Group SZHIF $6.78 $9.47 +40%
Tongkun Group 601233 ¥23.09 ¥14.53 -37%
HMT (Xiamen) New Technical Materials Co 603306 ¥110.20 ¥13.36 -88%
Far Eastern New Century Corporation 1402 28.65 TWD 32.97 TWD +15%
K.P.R. Mill Limited KPRMILL ₹1,181 ₹467.49 -60%
Shijiazhuang ChangShan BeiMing Technology Co 000158 ¥15.43 ¥2.27 -85%
Zhejiang Orient Holdings 600120 ¥4.47 ¥2.25 -50%
Vardhman Textiles Limited VTL ₹666.25 ₹437.96 -34%
Shandong Fiberglass Group 605006 ¥21.80 ¥2.76 -87%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Trident Texofab Limited (TTFL) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹9.40 versus a price of ₹34.19 — about −73% (overvalued). Model-based estimate, not financial advice.
What is the fair value of TTFL?
Our model-based fair value for Trident Texofab Limited is ₹9.40 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹34.19.
What is the quality score of TTFL?
Trident Texofab Limited has a Quality Score of 24/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Trident Texofab Limited (TTFL)?
Trident Texofab Limited reported trailing-twelve-month revenue of about ₹1.2B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of TTFL?
The net profit margin of Trident Texofab Limited is about 0.6%, meaning it keeps roughly 0.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.